The compression of morbidity. 1983.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMC 2690269)

Published in Milbank Q on January 01, 2005

Authors

James F Fries

Articles citing this

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 2.42

From the Lab to the Front Line: How Individual Biogerontologists Navigate their Contested Field. J Aging Stud (2008) 1.05

Transitions among Health States Using 12 Measures of Successful Aging in Men and Women: Results from the Cardiovascular Health Study. J Aging Res (2012) 0.93

Heart failure with a normal ejection fraction (HFNEF): embracing complexity. J Card Fail (2009) 0.86

Age at Childbearing over Two Generations and Grandchildren's Cognitive Achievement. Res Soc Stratif Mobil (2014) 0.81

Indicators for healthy ageing--a debate. Int J Environ Res Public Health (2013) 0.81

Are "anti-aging medicine" and "successful aging" two sides of the same coin? Views of anti-aging practitioners. J Gerontol B Psychol Sci Soc Sci (2013) 0.80

A person-centred approach to health promotion for persons 70+ who have migrated to Sweden: promoting aging migrants' capabilities implementation and RCT study protocol. BMC Geriatr (2015) 0.79

Expansion or compression of long-term care in Germany between 2001 and 2009? A small-area decomposition study based on administrative health data. Popul Health Metr (2016) 0.78

The effect of acculturation on frailty among older Mexican Americans. J Aging Health (2010) 0.77

The Demographic Stretch of the Arc of Life: Social and Cultural Changes That Follow the Demographic Transition. Glob Health Sci Pract (2015) 0.75

Models for projecting supply and demand for nurses in Israel. Isr J Health Policy Res (2015) 0.75

Identifying High-Cost, High-Risk Patients Using Administrative Databases in Tuscany, Italy. Biomed Res Int (2017) 0.75

Molecular and physiological manifestations and measurement of aging in humans. Aging Cell (2017) 0.75

Articles cited by this

Aging, natural death, and the compression of morbidity. N Engl J Med (1980) 17.40

Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'. Philos Trans R Soc Lond B Biol Sci (2015) 12.50

Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q Health Soc (1982) 4.26

General theory of mortality and aging. Science (1960) 2.70

Dementia in the elderly: the silent epidemic. Ann Intern Med (1982) 2.24

Changing United States life-style and declining vascular mortality: cause or coincidence? N Engl J Med (1977) 2.14

Frequency and clinical description of high-cost patients in 17 acute-care hospitals. N Engl J Med (1979) 1.91

Coronary heart disease in residents of Rochester, Minnesota. II. Mortality, incidence, and survivorship, 1950-1975. Mayo Clin Proc (1981) 1.73

The effects of choice and enhanced personal responsibility for the aged: a field experiment in an institutional setting. J Pers Soc Psychol (1976) 1.60

Longitudinal variations in maximal oxygen intake with age and activity. J Appl Physiol (1972) 1.50

Long-term effects of a control-relevant intervention with the institutionalized aged. J Pers Soc Psychol (1977) 1.44

Energy expenditure, cigarette smoking, and blood pressure level as related to death from specific diseases. Am J Epidemiol (1978) 1.36

Coronary heart disease in residents of Rochester, Minnesota, 1950-1975. I. Background and study design. Mayo Clin Proc (1981) 1.33

Disuse and aging. JAMA (1982) 1.28

Natural history of male psychologic health: effects of mental health on physical health. N Engl J Med (1979) 1.27

Physical fitness, aging, and psychomotor speed: a review. J Gerontol (1980) 1.26

Evolution of human longevity: a critical overview. Mech Ageing Dev (1979) 1.05

The cell biology of human aging. Sci Am (1980) 1.02

The regulation of physiological changes during mammalian aging. Q Rev Biol (1976) 0.99

Patterns of incidence and trends in diagnostic classification of cerebrovascular disease in Washington County, Maryland, 1969-1971 to 1974-1976. Am J Epidemiol (1982) 0.88

Environmental determinants of memory improvement in late adulthood. J Pers Soc Psychol (1979) 0.88

Toward an effective treatment of Alzheimer's disease. Ann Intern Med (1983) 0.81

Recent health gains for adults. N Engl J Med (1982) 0.80

Articles by these authors

The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care (2007) 13.29

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol (2010) 10.65

The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol (2003) 4.53

Do workplace health promotion (wellness) programs work? J Occup Environ Med (2014) 3.80

Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med (2008) 3.66

The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes (2003) 3.04

Lifestyle habits and compression of morbidity. J Gerontol A Biol Sci Med Sci (2002) 2.40

Midlife body mass index and hospitalization and mortality in older age. JAMA (2006) 2.36

Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum (2005) 2.30

Aging, natural death, and the compression of morbidity. 1980. Bull World Health Organ (2002) 2.22

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis. JAMA (2007) 2.17

Better assessment of physical function: item improvement is neglected but essential. Arthritis Res Ther (2009) 2.04

Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. J Rheumatol (2002) 1.98

Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire. J Rheumatol (2004) 1.91

Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis. Arthritis Rheum (2013) 1.72

Long-term randomized controlled trials of tailored-print and small-group arthritis self-management interventions. Med Care (2004) 1.63

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann Rheum Dis (2006) 1.62

Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients. Am J Med (2003) 1.47

Postponed development of disability in elderly runners: a 13-year longitudinal study. Arch Intern Med (2002) 1.43

Cardiovascular risk profile earlier in life and Medicare costs in the last year of life. Arch Intern Med (2005) 1.42

Osteoarthritis, exercise, and knee replacement. J Rheumatol (2012) 1.41

Lifestyle risk factors predict disability and death in healthy aging adults. Am J Med (2012) 1.27

Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI). Arthritis Res Ther (2004) 1.27

Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol (2007) 1.19

Improving patient reported outcomes using item response theory and computerized adaptive testing. J Rheumatol (2007) 1.17

Primary knee and hip arthroplasty among nonagenarians and centenarians in the United States. Arthritis Rheum (2007) 1.15

Upper-extremity and mobility subdomains from the Patient-Reported Outcomes Measurement Information System (PROMIS) adult physical functioning item bank. Arch Phys Med Rehabil (2013) 1.09

Patient self-management in arthritis? Yes! J Rheumatol (2003) 1.08

Associations of changes in exercise level with subsequent disability among seniors: a 16-year longitudinal study. J Gerontol A Biol Sci Med Sci (2006) 1.07

Reducing disability in older age. JAMA (2002) 1.06

The methotrexate therapeutic response in rheumatoid arthritis. J Rheumatol (2002) 1.03

Long distance running and knee osteoarthritis. A prospective study. Am J Prev Med (2008) 1.01

Aerobic exercise and its impact on musculoskeletal pain in older adults: a 14 year prospective, longitudinal study. Arthritis Res Ther (2005) 1.00

Items, Instruments, Crosswalks, and PROMIS. J Rheumatol (2009) 0.98

Disability in rheumatoid arthritis in the era of biological treatments. Ann Rheum Dis (2011) 0.96

Measuring effectiveness of drugs in observational databanks: promises and perils. Arthritis Res Ther (2004) 0.94

Framing health messages based on anomalies in time preference. Med Sci Monit (2005) 0.93

Regular vigorous physical activity and disability development in healthy overweight and normal-weight seniors: a 13-year study. Am J Public Health (2008) 0.88

Patient perspective: choosing or developing instruments. J Rheumatol (2011) 0.85

Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes. J Rheumatol (2011) 0.85

A first step to assess harm and benefit in clinical trials in one scale. J Clin Epidemiol (2009) 0.85

Rate of death due to leukemia/lymphoma in patients with rheumatoid arthritis. Arthritis Rheum (2003) 0.85

A low tension between individual and societal time aspects in health improved outcomes. J Clin Epidemiol (2006) 0.85

Discounting and risk characteristics in clinical decision-making. Med Sci Monit (2006) 0.81

New instruments for assessing disability: not quite ready for prime time. Arthritis Rheum (2004) 0.80

Time-related issues with application to health gains and losses. J Clin Epidemiol (2002) 0.79

Challenges and progress in adverse event ascertainment and reporting in clinical trials. J Rheumatol (2005) 0.78

The potential perils of informed consent. Mcgill J Med (2008) 0.78

Comparative risks of non-prescription analgesics: a structured topic review and research priorities. Expert Opin Drug Saf (2011) 0.78

Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update. J Rheumatol (2005) 0.78

Rheumatologist perceptions of sources of health care disparities in minority rheumatoid arthritis patients. J Clin Rheumatol (2009) 0.77

Frailty and education in the Hispanic Health and Nutrition Examination Survey. J Health Care Poor Underserved (2002) 0.77

Rheumatoid arthritis: radiographic progression is getting milder. J Rheumatol (2005) 0.77

The irreversible component of the disability index of the health assessment questionnaire: comment on the article by Aletaha et al. Arthritis Rheum (2007) 0.76

Comparison of the health assessment questionnaire disability index and the short form 36 physical functioning subscale using Rasch analysis: comment on the article by Taylor and McPherson. Arthritis Rheum (2008) 0.76

How to ascertain drug safety in the context of benefit. Controversies and concerns. J Rheumatol (2009) 0.75

Science as experiment; science as observation. Nat Clin Pract Rheumatol (2006) 0.75